Zobrazeno 1 - 10
of 307
pro vyhledávání: '"Jeremy S Abramson"'
Autor:
Hazim S. Ababneh, Andrea K. Ng, Matthew J. Frigault, Jeremy S Abramson, Patrick Connor Johnson, Caron A. Jacobson, Chirayu G. Patel
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Despite the success of CD19-targeted chimeric antigen receptor (CAR T)-cell therapy in patients with relapsed/refractory large B-cell lymphoma (LBCL), there is a need for effective salvage strategies post-CAR T-cell therapy failure. We conducted a mu
Externí odkaz:
https://doaj.org/article/4a2ced42a6da469fb8f751f77f667624
Autor:
Pim G. N. J. Mutsaers, Jeremy S. Abramson, Manjusha Namuduri, Jingjin LI, Nickolas A. Sophos, Min Zhu, Jurriaan Brouwer-Visser, Hesham Mohamed, Aafia Chaudhry, Andrew J. Davies
Publikováno v:
HemaSphere, Vol 7, p e7082565 (2023)
Externí odkaz:
https://doaj.org/article/a992aa44d60b4c1c98a18c290e3369d6
Autor:
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S. Abramson, Jacob D. Soumerai, Andrew J. Yee, Andrew R. Branagan, Elizabeth K. O’Donnell, Anna Saucier, Caron A. Jacobson, Matthew J. Frigault, Noopur S. Raje
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 10, Pp 1-12 (2022)
Abstract Chimeric antigen receptor T cells (CAR T) are groundbreaking therapies but may cause significant toxicities including cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and cytopenias. Granulocyt
Externí odkaz:
https://doaj.org/article/3228817cf75c47368f94792a61f6aa4d
Autor:
Martin Hutchings, Stephen M. Ansell, Joseph M. Connors, Won Seog Kim, Andrea Gallamini, Radhakrishnan Ramchandren, Jonathan W. Friedberg, Ranjana Advani, Andrew M. Evens, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Hyeon-Seok Eom, Jeremy S. Abramson, Cassie Dong, Frank Campana, Keenan Fenton, Markus Puhlmann, David J. Straus, John Radford
Publikováno v:
HemaSphere, Vol 6, Pp 4-5 (2022)
Externí odkaz:
https://doaj.org/article/e69a657c30944b31b31f0be9c6f36ad9
Autor:
Jeremy S. Abramson, Elizabeth Bengston, Robert Redd, Jeffrey A. Barnes, Tak Takvorian, Lubomir Sokol, Frederick Lansigan, Philippe Armand, Bijal Shah, Eric Jacobsen, Rosalba Martignetti, Elyce Turba, Sara Metzler, Victoria Patterson, Ann S. LaCasce, Celeste M. Bello
Publikováno v:
Blood Advances. 7:1130-1136
ABVD (Adriamycin, bleomycin, vinblastine, dacarbazine) with or without radiation has been the standard treatment for limited-stage Hodgkin lymphoma (HL) but carries risks of bleomycin lung injury and radiation toxicity. Brentuximab vedotin (BV) is ap
Autor:
Christine E. Ryan, Danielle M. Brander, Paul M. Barr, Svitlana Tyekucheva, Liam R. Hackett, Mary C. Collins, Stacey M. Fernandes, Yue Ren, Yinglu Zhou, Mikaela M. McDonough, Heather A. Walker, Monica R. McEwan, Jeremy S. Abramson, Eric D. Jacobsen, Ann S. LaCasce, David C. Fisher, Jennifer R. Brown, Matthew S. Davids
Publikováno v:
Leukemia. 37:835-842
Autor:
Megan J. Fitzpatrick, Vandana Sundaram, Amy Ly, Jeremy S. Abramson, Ronald Balassanian, Matthew C. Cheung, Stephen L. Cook, Lorenzo Falchi, Annabel K. Frank, Srishti Gupta, Robert P. Hasserjian, Oscar Lin, Steven R. Long, Joshua R. Menke, Eric Mou, Daniel R. Reed, Roberto Ruiz‐Cordero, Ashley K. Volaric, Linlin Wang, Kwun Wah Wen, Yi Xie, Sara L. Zadeh, Dita Gratzinger
Publikováno v:
Cancer Cytopathology. 131:279-288
Few studies have evaluated diagnostic yield of small volume biopsies (SVB) for the diagnosis and management of follicular lymphoma (FL).The authors performed a multi-institutional retrospective analysis of SVBs including fine-needle aspiration (FNA)
Autor:
Michael G. Milligan, Elizabeth Bigger, Jeremy S. Abramson, Aliyah R. Sohani, Musimar Zola, Mukendi K.A. Kayembe, Heluf Medhin, Gita Suneja, Shahin Lockman, Bruce A. Chabner, Scott L. Dryden-Peterson
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-11 (2018)
Purpose: Botswana has a high prevalence of HIV infection. Currently, there are few data regarding the sociodemographic factors, clinical characteristics, and outcomes of non-Hodgkin lymphoma (NHL)—an AIDS-defining cancer—in the country. Patients
Externí odkaz:
https://doaj.org/article/5d3d9e1e0dc846a6bb750a3da4efd47a
Autor:
Jacob D. Soumerai, Allison Rosenthal, Shannon Harkins, Jessica Duffy, Carmen Mecca, Yingbing Wang, Ravinder K. Grewal, Areej R. El-Jawahri, Huiyun Liu, Cedric Menard, Ahmet Dogan, Lei Yang, Lisa M. Rimsza, Kurt Bantilan, Haley Martin, Matthew Lei, Sydney Mohr, Anna Kurilovich, Olga Kudryashova, Ekaterina Postovalova, Valentina Nardi, Jeremy S. Abramson, Roberto Chiarle, Andrew D. Zelenetz, Abner Louissaint
Publikováno v:
Blood. 140:1822-1826
Publikováno v:
Radiotherapy and Oncology. 175:65-72
An estimated 30-40% of patients with diffuse large B cell lymphoma (DLBCL) will either relapse or have refractory disease with first-line chemoimmunotherapy. The standard approach for relapsed/refractory disease is salvage chemotherapy followed by au